Cromoz announces CNT-based targeted cancer theranostic to enter human trials in early 2010

December 01, 2009 | Analyst Insight

Cromoz, a bionanotech startup based in North Carolina, recently announced that it would begin animal testing and, if all goes well, human testing of its carbon nanotubes (CNTs) in cancer therapies;...